论文部分内容阅读
急性肺损伤(ALI)/急性呼吸窘迫综合征(ARDS)是一种临床常见危重症,病死率极高,严重威胁重症患者的生命,并影响存活患者的生存质量。尽管我国重症医学已有了长足发展,但对 ALI/ARDS 的认识与治疗状况尚不容乐观。中华医学会重症医学分会以循证医学证据为基础,经广泛征求意见和建议,反复认真讨论,达成成人 ALI/ARDS 诊断与治疗的共识,旨在对成人 ALI/ARDS 诊断与治疗进行规范。中华医学会重症医学分会还将依据循证医学证据的进展及新的共识对 ALI/ARDS 诊断与治疗指南进行更新。指南中的推荐意见依据2001年国际感染论坛(ISF)提出的 Delphi 分级标准,指南中涉及的文献按照研究方法和结果分成5个层
Acute lung injury (ALI) / acute respiratory distress syndrome (ARDS) is a common clinical critically ill illness with extremely high case-fatality rates that seriously threaten the lives of critically ill patients and affect the quality of life of surviving patients. Although the rapid development of critical care medicine in our country, the status of understanding and treatment of ALI / ARDS is still not optimistic. Based on the evidence of evidence-based medicine, the Chinese Medical Association’s Critical Care Medicine Sub-council, after extensive solicitation of opinions and suggestions, repeatedly discussed and reached consensus on the diagnosis and treatment of adult ALI / ARDS in order to standardize the diagnosis and treatment of adult ALI / ARDS. The Chinese Medical Association of Critical Care Medicine will also update the guidelines for diagnosis and treatment of ALI / ARDS based on the evidence-based evidence and the new consensus. The recommendations in the guideline are based on the Delphi grading criteria proposed by the International Forum on Infections (ISF) in 2001. The references in the guideline are grouped into five levels according to the research methods and results